Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Non-GIST Sarcomas
NCT00474994Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2007
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in sarcoma, leiomyosarcoma (LMS), dermatofibrosarcoma protuberans (DFSP), chordoma, desmoid tumor, sponsored by Memorial Sloan Kettering Cancer Center. Started Apr 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
sarcomaleiomyosarcoma (LMS)dermatofibrosarcoma protuberans (DFSP)chordomadesmoid tumor
Beyond the preview
Go deeper on NCT00474994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00474994.